Patrick Soon-Shiong touted sales of his closely scrutinized test without revealing the purchaser was on his payroll.
Patrick Soon-Shiong, the medical entrepreneur who has expanded his influence in Washington by cultivating close ties to both parties, has struggled to meet analysts’ expectations for sales of his GPS genetic test, the key to his plan to transform cancer treatment by matching patients with tailored drug treatments.
At the same time, sales of the GPS test are being boosted by purchases from hospitals and clinics associated with doctors who have financial ties to his network of for-profit and non-profit companies.
Of 1,286 tests of the GPS test sold in 2016, well over a hundred were by institutions linked to three doctors who have been on the payroll of one of the arms in Soon-Shiong’s network, according to a POLITICO review of financial documents and corporate filings.
